verrucarin j has been researched along with Leukemia P388 in 2 studies
*Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jarvis, BB; Mazzola, EP; Pavanasasivam, G; Stahly, GP | 1 |
| Bloem, RJ; Bunge, RH; French, JC; Smitka, TA | 1 |
2 other study(ies) available for verrucarin j and Leukemia P388
| Article | Year |
|---|---|
Antileukemic compounds derived from the chemical modification of macrocyclic trichothecenes. 1. Derivatives of verrucarin A.
Topics: Animals; Antineoplastic Agents, Phytogenic; Epoxy Compounds; Hydrolysis; Hydroxylation; Leukemia P388; Mice; Oxidation-Reduction; Structure-Activity Relationship | 1980 |
Two new trichothecenes, PD 113,325 and PD 113,326.
Topics: Animals; Antineoplastic Agents; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Sesquiterpenes; Stereoisomerism; Trichothecenes | 1984 |